多発性骨髄腫における動的マルチモーダル生存予測モデル ―遺伝子発現、経時的検査値、治療歴を統合―

ad

2026-09-14 東京大学

東京大学・理化学研究所などの研究グループは、多発性骨髄腫患者の診断後1~18か月の情報から、その後の残存全生存期間を予測する動的マルチモーダルモデルを開発した。診断時の遺伝子発現データをDeepInsight法で画像化し、10種類の検査値の経時変化と治療履歴を深層学習で統合。752人の公開臨床データで評価した結果、診断時の情報だけを用いる従来手法を上回る予測性能を示し、治療経過に応じて患者の生存リスクを更新できる可能性が示された。さらに、モデルの判断因子からユビキチン・プロテアソーム系、小胞体ストレス、インターフェロンα応答など、既知の骨髄腫関連シグナルも確認された。長期治療を要する疾患における個別化予後予測への応用が期待される。

多発性骨髄腫における動的マルチモーダル生存予測モデル ―遺伝子発現、経時的検査値、治療歴を統合―
多発性骨髄腫 AI治療支援

<関連情報>

遺伝子発現、縦断的検査値、および治療歴を統合した多発性骨髄腫における動的なマルチモーダル生存予測 Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratory measurements, and treatment history

Shangru Jia,Artem Lysenko,Keith A Boroevich,Alok Sharma,Tatsuhiko Tsunoda
Briefings in Bioinformatics  Published:07 September 2026
DOI:https://doi.org/10.1093/bib/bbag475

Abstract

Prognostic stratification in multiple myeloma (MM) relies on staging systems fixed at diagnosis, discarding temporal information accumulated during treatment. We developed a dynamic multimodal framework that predicts residual overall survival from observation windows of 1–18 months post-diagnosis. The model integrates DeepInsight-transformed gene expression, longitudinal trajectories of 10 laboratory analytes, and treatment history through missingness-aware gated fusion. On the Multiple Myeloma Research Foundation (MMRF) cohort from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile (CoMMpass) study (n = 752), five-fold-specific models trained on the development dataset achieved a mean concordance index (C-index) of 0.773 ± 0.024 and 1-year time-dependent area under the receiver operating characteristic curve (AUC) of 0.789 ± 0.021 on a common held-out CoMMpass validation split, outperforming the evaluated survival-learning baselines including DeepSurv, a Cox proportional hazards neural network, and random survival forests. Kaplan–Meier stratification showed significant separation at all primary landmarks (log-rank P< .001⁠, hazard ratios 3.46–3.93). A distilled student model retaining only the DeepInsight gene expression representation and five baseline clinical features transferred to an independent microarray cohort (GSE24080, n = 507) without retraining, achieving a C-index of 0.672 and a time-dependent AUC at 1-year of 0.740, supporting cross-cohort transferability in a reduced-input setting. Interpretability analyses recovered ubiquitin-proteasome, endoplasmic reticulum (ER) stress, and Interferon Alpha Response signals consistent with established myeloma biology. These findings support the potential of dynamic multimodal modeling for longitudinal prognostic assessment in MM.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました